Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.
Eurofins Scientific
has signed an agreement to acquire the assets of the Discovery and Development Solutions (DDS) business of Merck Millipore (EMD Millipore in the United States and Canada), the Life Science division of Merck KGaA, Darmstadt, Germany. DDS is a provider of bioanalytical testing and early stage discovery services and products to the biopharmaceutical market. DDS generates revenues of about $35 million with 175 employees from its three sites in Missouri, Scotland, and England.
In addition, DDS provides expertise in bioanalytical testing to support clinical trials. The acquisition of DDS will strengthen Eurofins' presence in the early stage discovery solutions market while adding expertise in high-quality bioanalytical services, according to the company. After the transaction, DDS will continue to provide products and services to Merck KGaA's pharma business.
As part of the agreement, DDS will continue to be led by Christina Shasserre, who has headed the DDS business since 2010. Shasserre will become president of Eurofins Pharma BioAnalytical Services, as the company will be renamed following the closing. The transaction is subject to standard closing conditions, which the parties expect to complete within 90 days.
Source:
Eurofins Scientific
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.